IDEX Biometrics (IDXAF) Ratios
IDEX Biometrics Ratios
IDXAF's free cash flow for Q2 2026 was $-4.67M. For the 2026 fiscal year, IDXAF's free cash flow was decreased by $-6.81K and operating cash flow was $-4.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.58 | 2.67 | 1.64 | 4.74 | 8.50 |
| Quick Ratio | 0.31 | 1.07 | 1.12 | 3.85 | 8.22 |
| Cash Ratio | 0.16 | 0.57 | 0.92 | 3.20 | 7.68 |
| Solvency Ratio | -1.59 | -2.14 | -1.88 | -3.18 | -3.87 |
| Operating Cash Flow Ratio | -1.93 | -5.07 | -2.18 | -6.34 | -6.23 |
| Short-Term Operating Cash Flow Coverage | -7.34 | 0.00 | -5.32 | 0.00 | 0.00 |
| Net Current Asset Value | $ 878.92K | $ 3.67M | $ 6.71M | $ 17.66M | $ 33.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.23 | 0.28 | 0.40 | 0.01 |
| Debt-to-Equity Ratio | 1.33 | 0.50 | 0.61 | 0.51 | 0.01 |
| Debt-to-Capital Ratio | 0.57 | 0.34 | 0.38 | 0.34 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.30 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 5.23 | 2.18 | 2.20 | 1.27 | 1.12 |
| Debt Service Coverage Ratio | -4.56 | -3.95 | -23.12 | -905.61 | -955.71 |
| Interest Coverage Ratio | -10.28 | -9.08 | -3.99 | -950.58 | -1011.29 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.08 | 0.01 | 0.05 | 0.06 | 0.00 |
| Net Debt to EBITDA | -0.12 | -0.04 | 0.02 | 0.15 | 1.13 |
| Profitability Margins | |||||
| Gross Profit Margin | -1372.84% | -100.24% | 5.58% | 20.72% | 55.85% |
| EBIT Margin | -4025.60% | -1445.66% | -6620.42% | -764.25% | -1103.49% |
| EBITDA Margin | -3842.40% | -1146.37% | -6595.66% | -731.21% | -1040.04% |
| Operating Profit Margin | -4025.60% | -2604.40% | -648.63% | -766.59% | -1103.87% |
| Pretax Profit Margin | -3953.94% | -1732.34% | -643.75% | -799.07% | -1143.03% |
| Net Profit Margin | -3937.80% | -1718.07% | -643.37% | -798.14% | -1146.13% |
| Continuous Operations Profit Margin | -3937.80% | -1718.07% | -6515.73% | -798.19% | -1146.20% |
| Net Income Per EBT | 99.59% | 99.18% | 99.94% | 99.88% | 100.27% |
| EBT Per EBIT | 98.22% | 66.52% | 99.25% | 104.24% | 103.55% |
| Return on Assets (ROA) | -134.83% | -140.32% | -106.68% | -112.56% | -77.26% |
| Return on Equity (ROE) | -705.25% | -306.58% | -234.95% | -142.99% | -86.28% |
| Return on Capital Employed (ROCE) | -330.81% | -320.41% | -213.55% | -130.80% | -83.10% |
| Return on Invested Capital (ROIC) | -240.37% | -300.33% | -111.95% | -128.50% | -82.31% |
| Return on Tangible Assets | -135.66% | -148.55% | -115.86% | -122.97% | -83.04% |
| Earnings Yield | -4.18% | -0.51% | -0.08% | -0.06% | -0.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.71 | 0.90 | 4.23 | 1.80 | 1.84 |
| Payables Turnover | 3.33 | 1.98 | 5.68 | 2.11 | 1.83 |
| Inventory Turnover | 0.68 | 0.30 | 0.61 | 0.73 | 1.02 |
| Fixed Asset Turnover | 5.13 | 2.02 | 1.60 | 1.54 | 1.71 |
| Asset Turnover | 0.03 | 0.08 | 0.17 | 0.14 | 0.07 |
| Working Capital Turnover Ratio | 0.06 | 0.12 | 0.31 | 0.16 | 0.14 |
| Cash Conversion Cycle | 941.05 | 1422.33 | 618.10 | 530.28 | 357.85 |
| Days of Sales Outstanding | 512.29 | 404.06 | 86.33 | 203.19 | 198.05 |
| Days of Inventory Outstanding | 538.51 | 1202.51 | 596.03 | 500.36 | 359.18 |
| Days of Payables Outstanding | 109.75 | 184.23 | 64.26 | 173.27 | 199.38 |
| Operating Cycle | 1050.80 | 1606.57 | 682.36 | 703.55 | 557.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.22 | -0.04 | -0.11 | -0.16 | -0.15 |
| Free Cash Flow Per Share | -0.22 | -0.04 | -0.11 | -0.16 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | -195.45 | -4383500.00 | -111.13 | -119.46 | -194.79 |
| Capital Expenditure Coverage Ratio | -195.45 | -4383500.00 | -111.13 | -119.46 | -194.79 |
| Operating Cash Flow Coverage Ratio | -4.44 | -7.37 | -3.89 | -2.74 | -66.99 |
| Operating Cash Flow to Sales Ratio | -32.89 | -20.85 | -6.52 | -7.79 | -9.67 |
| Free Cash Flow Yield | -3.51% | -0.62% | -0.08% | -0.06% | -0.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.23 | -193.45 | -1326.17 | -1584.42 | -4524.65 |
| Price-to-Sales (P/S) Ratio | 941.62 | 3347.89 | 8532.13 | 12645.93 | 51858.22 |
| Price-to-Book (P/B) Ratio | 168.64 | 597.41 | 3115.80 | 2265.54 | 3903.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -28.48 | -160.58 | -1296.04 | -1608.85 | -5334.98 |
| Price-to-Operating Cash Flow Ratio | -28.63 | -160.58 | -1307.70 | -1622.32 | -5362.36 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 2.84 | 38.52 | 176.11 | -3531.25 |
| Enterprise Value Multiple | -24.63 | -292.08 | -129.34 | -1729.31 | -4985.07 |
| Enterprise Value | 247.42M | 2.82B | 35.42B | 51.74B | 147.24B |
| EV to EBITDA | -24.63 | -292.08 | -129.34 | -1729.31 | -4985.07 |
| EV to Sales | 946.28 | 3348.38 | 8531.06 | 12644.84 | 51846.45 |
| EV to Free Cash Flow | -28.62 | -160.60 | -1295.88 | -1608.71 | -5333.77 |
| EV to Operating Cash Flow | -28.77 | -160.60 | -1307.54 | -1622.18 | -5361.15 |
| Tangible Book Value Per Share | 0.04 | 0.01 | 0.04 | 0.10 | 0.19 |
| Shareholders’ Equity Per Share | 0.04 | 0.01 | 0.04 | 0.11 | 0.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.01 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
| Net Income Per Share | -0.26 | -0.03 | -0.11 | -0.16 | -0.18 |
| Tax Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.98 | 1.20 | 0.10 | 1.05 | 1.04 |
| Research & Development to Revenue | 5.36 | 2.92 | 0.88 | 0.79 | 0.94 |
| SG&A to Revenue | 11.05 | 5.01 | 0.00 | 0.51 | 7.43 |
| Stock-Based Compensation to Revenue | -1.80 | 0.42 | 0.31 | 0.66 | 0.97 |
| Income Quality | 0.86 | 1.20 | 1.01 | 0.98 | 0.85 |
Currency in NOK